Search Results - "Allisson Monteiro da Silva"

Vital dye is enough for inguinal sentinel lymph node biopsy in melanoma patients by Oliveira Filho, Renato Santos de, Silva, Allisson Monteiro da, Hochman, Bernardo, Oliveira, Renato Leão de, Arcuschin, Liliana, Wagner, Jairo, Yamaga, Lílian Yuri, Ferreira, Lydia Masako

“…The importance of gamma probe detection (GPD) combined with vital dye for sentinel node (SN) biopsy is well accepted. We evaluated the efficacy of patent blue…”
Get full text

Relevance of micrometastases detected by reverse transcriptase-polymerase chain reaction for melanoma recurrence: systematic review and meta-analysis by da Silva, Allisson Monteiro, de Oliveira Filho, Renato Santos, Ferreira, Lydia Masako, Saconato, Humberto

“…Cutaneous melanoma presents significant morbidity and mortality. Nowadays, about 90% of them are diagnosed by clinical examination and most are localized…”
Get full text

Biosimilar trastuzumab active post marketing surveillance real world 2020 data update: Results from a patient support program for patients under treatment with the first biosimilar trastuzumab approved in Brazil by Silva, Allisson Monteiro da, Watanabe, Thais Tiemi Wepeck Oliveira, Honda, Eimy, Yamaguchi, Juliana

“…Abstract only e14504 Background: In 2017, biosimilar trastuzumab (Zedora) became the first biosimilar trastuzumab approved in Brazil. In May 2018 an active…”
Get full text

Biosimilar trastuzumab active post-marketing surveillance real-world data update: Results from a patient support program for patients under treatment with the first biosimilar trastuzumab approved in Brazil by Silva, Allisson Monteiro da, Paulo, Jaqueline Amália de, Watanabe, Thais Tiemi, Dib, Gislaine Villarta Capeleti

“…Abstract only e15626 Background: In 2017, biosimilar trastuzumab (Zedora) became the first biosimilar trastuzumab approved in Brazil. In 2019, biosimilar…”
Get full text

Active postmarketing surveillance: Results from a manufacturer's patient support program for patients under treatment with the first biosimilar trastuzumab (MYL-1401O) approved in Brazil by Silva, Allisson Monteiro da, Dib, Gislaine Villarta Capeleti, Saraiva, Emanuela Lopez Fernandes, Watanabe, Thais Tiemi, Paulo, Jaqueline Amália de

“…Abstract only e14000 Background: The development of biosimilars is increasing around the world, and facilitates patient’s access to these high-tech therapies…”
Get full text

A biópsia de linfonodo sentinela não deve ser recomendada para pacientes portadores de melanoma espesso by Oliveira Filho, Renato Santos de, Silva, Allisson Monteiro da, Oliveira, Daniel Arcuschin de, Oliveira, Gustavo Gianotto, Nahas, Fabio Xerfan

“…OBJETIVO: verificar se há alguma relação entre o estado histopatológico do linfonodo sentinela, a recorrência e a mortalidade decorrente do melanoma espesso em…”
Get full text

A biópsia de linfonodo sentinela não deve ser recomendada para pacientes portadores de melanoma espesso Sentinel node biopsy should not be recommended for patients with thick melanoma by Renato Santos de Oliveira Filho, Allisson Monteiro da Silva, Daniel Arcuschin de Oliveira, Gustavo Gianotto Oliveira, Fabio Xerfan Nahas

“…OBJETIVO: verificar se há alguma relação entre o estado histopatológico do linfonodo sentinela, a recorrência e a mortalidade decorrente do melanoma espesso em…”
Get full text

A biópsia de linfonodo sentinela não deve ser recomendada para pacientes portadores de melanoma espesso by Renato Santos de Oliveira Filho, Allisson Monteiro da Silva, Daniel Arcuschin de Oliveira, Gustavo Gianotto Oliveira, Fabio Xerfan Nahas

“…OBJETIVO: verificar se há alguma relação entre o estado histopatológico do linfonodo sentinela, a recorrência e a mortalidade decorrente do melanoma espesso em…”
Get full text

Recorrência em pacientes portadores de melanoma cutâneo submetidos a biópsia de linfonodo sentinela: seguimento mediano de 37 meses by Renato Santos de Oliveira Filho, Allisson Monteiro da Silva, Liliana Arcuschin, Jairo Wagner, Lilian Yuri Yamaga

“…OBJETIVO: A biópsia de linfonodo sentinela (BLS) representa um avanço na cirurgia oncológica para o microestadiamento do melanoma. Apresentamos nossa…”
Get full text

Recorrência em pacientes portadores de melanoma cutâneo submetidos a biópsia de linfonodo sentinela: seguimento mediano de 37 meses by Oliveira Filho, Renato Santos de, Silva, Allisson Monteiro da, Arcuschin, Liliana, Wagner, Jairo, Yamaga, Lilian Yuri

“…OBJETIVO: A biópsia de linfonodo sentinela (BLS) representa um avanço na cirurgia oncológica para o microestadiamento do melanoma. Apresentamos nossa…”
Get full text

Sentinel node biopsy should not be recommended for patients with thick melanoma by de Oliveira Filho, Renato Santos, da Silva, Allisson Monteiro, de Oliveira, Daniel Arcuschin, Oliveira, Gustavo Gianotto, Nahas, Fabio Xerfan

“…To ascertain whether there is any relationship between the state of the sentinel lymph node histopathology, recurrence and mortality from thick melanoma in…”
Get more information